Akari Therapeutics PLC (AKTX)
1.36
-0.11
(-7.48%)
USD |
NASDAQ |
May 03, 16:00
1.39
+0.03
(+2.21%)
After-Hours: 20:00
Akari Therapeutics 1 Year Total Returns (Daily): -62.22% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -62.22% |
May 02, 2024 | -59.73% |
May 01, 2024 | -54.05% |
April 30, 2024 | -57.48% |
April 29, 2024 | -64.66% |
April 26, 2024 | -68.82% |
April 25, 2024 | -68.20% |
April 24, 2024 | -66.19% |
April 23, 2024 | -72.74% |
April 22, 2024 | -73.41% |
April 19, 2024 | -72.21% |
April 18, 2024 | -72.50% |
April 17, 2024 | -71.15% |
April 16, 2024 | -71.13% |
April 15, 2024 | -70.02% |
April 12, 2024 | -64.41% |
April 11, 2024 | -69.86% |
April 10, 2024 | -65.86% |
April 09, 2024 | -68.66% |
April 08, 2024 | -66.63% |
April 05, 2024 | -64.77% |
April 04, 2024 | -63.93% |
April 03, 2024 | -61.92% |
April 02, 2024 | -58.45% |
April 01, 2024 | -58.45% |
Date | Value |
---|---|
March 28, 2024 | -50.71% |
March 27, 2024 | -60.43% |
March 26, 2024 | -62.38% |
March 25, 2024 | -62.08% |
March 22, 2024 | -63.80% |
March 21, 2024 | -61.83% |
March 20, 2024 | -58.70% |
March 19, 2024 | -62.88% |
March 18, 2024 | -61.73% |
March 15, 2024 | -61.82% |
March 14, 2024 | -64.19% |
March 13, 2024 | -62.93% |
March 12, 2024 | -63.12% |
March 11, 2024 | -62.94% |
March 08, 2024 | -63.97% |
March 07, 2024 | -63.14% |
March 06, 2024 | -67.65% |
March 05, 2024 | -64.34% |
March 04, 2024 | -64.50% |
March 01, 2024 | -64.30% |
February 29, 2024 | -65.94% |
February 28, 2024 | -67.83% |
February 27, 2024 | -67.76% |
February 26, 2024 | -67.56% |
February 23, 2024 | -66.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.08%
Minimum
Aug 17 2023
194.5%
Maximum
Mar 16 2021
-28.64%
Average
-24.08%
Median
Jan 06 2022
1 Year Total Returns (Daily) Benchmarks
DBV Technologies SA | -57.25% |
Cellectis SA | 60.75% |
Adaptimmune Therapeutics PLC | -15.00% |
Biodexa Pharmaceuticals Plc | -93.25% |
NuCana PLC | -78.47% |